top of page

​Symposium
“Shaping the Future in
Psychiatry & Mental Health”

Date and Venue

November 4, 2026

Carlton Hotel
Tel Aviv, Israel

​​​​​​​

​

​

​

The Fondation France-Israël is organizing a French-Israeli symposium in Tel Aviv, bringing together leading researchers, physicians, entrepreneurs, and innovation experts to explore the new frontiers of psychiatry and mental health.

​

Immuno-psychiatry, artificial intelligence and digital tools, new therapeutic approaches, neuromodulation, and post-traumatic stress care: French and Israeli experts will share their research and practices to identify new approaches to better diagnose, prevent, and treat psychiatric disorders.

 

But the ambition of the symposium goes beyond sharing knowledge: part of the program will be dedicated to working sessions designed to foster new collaborative projects between French and Israeli teams.

​

This symposium will be held in English.

​

Free registration is required with Muriel Haim at the following address: muriel.haim@gmail.com

​​​

image.png
santé mentale.png

Preliminary Program

​​​​​​​

​​​​​​

08:00 – 08:30 Welcome Coffee

​

08:30 – 08:45 Opening Remarks

FRANCE

H.E. Christophe Parisot — French Ambassador to Israel

 

ISRAEL

CEO, Clalit Healthcare Services — (TBC)
CEO, Brainsway

​

08:45 – 09:15 Keynotes — France / Israel

FRANCE

Prof. Marion Leboyer — Professor of Psychiatry, Université Paris-Est Créteil; CEO Fondation FondaMental; PEPR Propsy; Director, Translational NeuroPsychiatry laboratory, Inserm U955

“Goal of the Symposium & Presentation of the French Program in Precision Psychiatry PEPR PROPSY”

​

ISRAEL

Dr. Jordan Lewinski — Head of Mental Health Services, Clalit Health Services

​

09:15 – 09:20 Dr. Nitz Blach — Israel Innovation Authority

“Horizon Europe as platform for collaboration”

​

09:20 – 10:15 PRECISION PSYCHIATRY: PATIENT STRATIFICATION & TARGETED TREATMENTS

Immuno-Psychiatry: Towards New Treatment Targets

Moderator: Prof. Marion Leboyer, Université Paris-Est Créteil; CEO Fondation FondaMental; PEPR Propsy

 

ISRAEL

Prof. Michal Schwartz — Weizmann Institute of Science
“Towards new targets in Immuno-Psychiatry”

​

FRANCE

Prof. Laurent Groc — CNRS, Bordeaux
“Autoimmunity in neuropsychiatry: from molecule to patients”

Prof. David Klatzmann — Inserm & IL TOO, Paris
“Autism as a reversible neuroimmune condition: from experimental mouse models to clinical case reports”

​

10:15 – 10:45 Coffee Break

​

10:45 – 12:15 New Digital Tools & AI Towards Precision Psychiatry

Moderator: Dr. Eyal Erook — Head of AI Practice, S. Horowitz.

 

ISRAEL

Prof. Noam Shomron — Tel Aviv University
“AI in Genomics”

Dr. Orit Goldman — VP Biology, NeuroKaire
“New tools for patient stratification and drug discovery”

​

FRANCE

Léah Camarat & Andrij Kulakovskyi — Fondation FondaMental
“AI and mental health”

Daniel Szeteli — CEO, Semeia
“Telemonitoring in mental health disorders”

Prof. Mircea Polosan — Inserm, Grenoble
“Bimodal EEG-fNIRS in Bipolar Disorder: From Diagnostic Classification to Real-Time Monitoring of Emotion Regulation”

Dinah Weissmann — CSO, Alcediag
“RNA editing biomarker blood test for the diagnosis of bipolar disorder”

​

12:15 – 13:30 Lunch

​

13:30 – 15:00 New Therapeutics Towards Precision Psychiatry

Moderator: Dr. Anna Elgart, Teva Pharmaceuticals (TBC)

 

ISRAEL

Prof. Amir Krivoy — Geha Mental Health Center · Chair, Israel Society for Biological Psychiatry (ISBP)
“Metabolic Psychiatry – new targets for diagnosis and treatment”

Prof. Gil Zalsman — Tel Aviv University
“New targets for suicide prevention”

Prof. Ilana Gozes — Tel Aviv University
“Novel approaches to autism, from de novo mutated genes to future innovative therapeutics”

Elisabeth Kogan — CEO, Syneris
“New targets in psychiatry”

Dr. Eran Harary — CMO, Remepy

 

FRANCE/ISRAEL

Prof. Marion Leboyer & Prof. Jonathan Javitt — CEO, NRX Pharmaceuticals

Prof. Marion Leboyer & Prof. Mark Weiser — Sheba Medical Center
“New therapies in schizophrenia” - Lancet Schizophrenia Consortium

​

15:00 – 16:00 Neuromodulation Towards Precision Psychiatry

ISRAEL

Prof. Yair Bar-Haim — Tel Aviv University · Director, National Center for Traumatic Stress and Resilience

Brainsway

 

FRANCE

Prof. Mircea Polosan — Inserm, Grenoble

Jeremy Bercoff — CEO, Sonomind
Ultrasound in mental disorders

​

16:00 – 17:00 B2B – Building Collaborative Projects per Domain

Immunology · Digital tools & AI · New treatment targets · Neuromodulation

​

16:00–16:30 Group meetings

​

16:30–17:00 Restitution of projects per domain

​

17:00 – 18:00 PTSD Clinical Excellence: French–Israeli Perspectives on Hospital Psychiatry and the Care Pathway

Moderator: Gila Tolub, CEO ICAR Collective (TBC)

 

ISRAEL

Prof. Yair Bar-Haim — Tel Aviv University · Director, National Center for Traumatic Stress and Resilience

Prof. Asher Ben-Arieh — Hebrew University
“Peace of Mind platform”

 

FRANCE

Prof. Denis Peschanski — CNRS

Prof. Jacques Dayan — CHU Caen, Inserm (TBC)

​

18:00 Conclusion of the Meeting

​

19:00 Reception & Networking Event

​​

​

​

​

​

bottom of page